Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care

Senta Frol; Matija Zupan; Mišo Šabovič; Pawel Kermer; Adnan H. Siddiqui; Elad I. Levy

doi:10.1007/s40263-026-01291-y

Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care

Senta Frol
, Matija Zupan
, Mišo Šabovič
, Pawel Kermer
, Adnan H. Siddiqui
, Elad I. Levy

Neurosurgery

University Medical Center Ljubljana
University of Ljubljana
University of Göttingen
Friesland Kliniken GmbH

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	733-736
Number of pages	4
Journal	CNS Drugs
Volume	40
Issue number	6
DOIs	https://doi.org/10.1007/s40263-026-01291-y
State	Published - Jun 2026

Access to Document

10.1007/s40263-026-01291-y

Cite this

@article{d2da392606ad486ab72987b73e3b333e,

title = "Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care",

author = "Senta Frol and Matija Zupan and Mi{\v s}o {\v S}abovi{\v c} and Pawel Kermer and Siddiqui, \{Adnan H.\} and Levy, \{Elad I.\}",

year = "2026",

month = jun,

doi = "10.1007/s40263-026-01291-y",

language = "English",

volume = "40",

pages = "733--736",

journal = "CNS Drugs",

issn = "1172-7047",

publisher = "Adis",

number = "6",

}

TY - JOUR

T1 - Andexanet Alfa Withdrawn from the US

T2 - Implications for Intracranial Hemorrhage Care

AU - Frol, Senta

AU - Zupan, Matija

AU - Šabovič, Mišo

AU - Kermer, Pawel

AU - Siddiqui, Adnan H.

AU - Levy, Elad I.

PY - 2026/6

Y1 - 2026/6

UR - https://www.scopus.com/pages/publications/105036339263

U2 - 10.1007/s40263-026-01291-y

DO - 10.1007/s40263-026-01291-y

M3 - Comment/debate

C2 - 42020835

AN - SCOPUS:105036339263

SN - 1172-7047

VL - 40

SP - 733

EP - 736

JO - CNS Drugs

JF - CNS Drugs

IS - 6

ER -

Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care

Access to Document

Other files and links

Fingerprint

Cite this